Wall Street Journal @WSJ reporter covering pharma. Past: @DowJones Newswires, @LansReporter, Montgomeryville Spirit. 215-881-7127, peter.loftus@wsj.comWall Street Journal @WSJ reporter covering pharma. Past: @DowJones Newswires, @LansReporter, Montgomeryv

Drugmakers Place Big Bets on Cancer Medicines

wsj.com — Despite a growing outcry over the rising cost of cancer treatments, drugmakers are placing multibillion-dollar bets on new medicines they expect will command premium prices and generate big sales. France's Sanofi SA said Thursday it made an unsolicited, $9.3 billion offer to purchase San Francisco-based Medivation Inc., which sells a prostate-cancer drug that recently drew criticism from members of Congress over its price tag.

Eli Lilly Revenue Boosted by New Drug Sales

wsj.com — Eli Lilly Co. said revenue rose in its latest quarter as sales of new drugs helped offset declines in some established products. Lilly also cut its profit forecast for the year, citing the Venezuelan financial crisis and a resulting $203.9 million accounting charge.

U.S. Drug Spending Climbs

wsj.com — Total spending on prescription drugs in the U.S. rose 12.2% to nearly $425 billion in 2015, continuing a steep climb fueled by the introduction in recent years of expensive new drugs for cancer and infections, as well as price hikes for older drugs, according to a new report.

FDA Panel Backs Approval of Liver-Disease Drug

wsj.com — A U.S. Food and Drug Administration advisory panel recommended the agency approve a new drug for the treatment of a rare liver condition-the latest milestone in a rapidly growing market for liver-disease drugs.

FDA Approves Rheumatoid Knockoff

wsj.com — U.S. health regulators have approved for sale Pfizer Inc.'s lower-priced "biosimilar" version of Remicade, a Johnson & Johnson and Merck & Co. treatment for rheumatoid arthritis. Inflectra-which Pfizer Inc. acquired as part of its merger with Hospira-is already approved for sale in Canada, Mexico, Australia and parts of Europe. It...

Merck Gets Win Over Gilead in Hepatitis C Drug Patent Dispute

wsj.com — Merck & Co. won a legal victory over rival Gilead Sciences Inc. on Tuesday when a California jury upheld the validity of two patents that Merck says should entitle it to a portion of the multibillion-dollar sales of Gilead's hepatitis C drugs. The financial repercussions of the decision weren't immediately clear.

Bristol-Myers Bucks Trend Toward Precision Medicine

wsj.com — Bristol-Myers Squibb Co. has sprinted to an early lead in the race to sell a new class of cancer treatment by bucking the trend toward precision medicine. For years, drug companies tried to sell medicines to as many patients as possible.

Gilead Tries to Block Merck’s Patent Claims on New Hepatitis C Drugs

wsj.com — A high-stakes battle between two drug companies over the multibillion-dollar sales of new hepatitis C treatments is kicking off in a California courtroom this week. Gilead Sciences Inc. hopes to convince a jury in federal court in San Jose that it shouldn't have to share any of the sales of its blockbuster hepatitis C drugs Sovaldi and Harvoni with rival Merck & Co., which wants a cut.

Pharma firms scramble to develop Zika virus vaccine

bdlive.co.za — INTERNATIONAL health officials vowed after West Africa's Ebola crisis to be better armed for the next epidemic with vaccines, drugs and diagnostic tests. Now the next one - Zika - is here and in an echo of Ebola, researchers are scrambling to develop medical tools to fight the virus.

Drugmakers Scramble to Find Zika Vaccine

wsj.com — International health officials vowed after West Africa's Ebola crisis to be better armed for the next epidemic with vaccines, drugs and diagnostic tests. Now the next one-Zika-is here and in an echo of Ebola, researchers are scrambling to develop medical tools to fight the virus. About 15 companies are working on Zika vaccines, most in...
More Articles →
Apr 29, 2016

M&A dance underway as Sanofi CEO seeks talks with Medivation over $9.3 billion offer httpon.wsj.com/1SCGPVN @WSJ@WSJi@NBisserbe

Apr 29, 2016

And PP&L, the electric utility living there in Allentown, is STILL independent... httptwitter.com/WSJ/status/725…

Apr 29, 2016

@NeilShahWSJ Days after Prince died, I forked over $95 a ticket to see McCartney at Phillies stadium this summer. Related events.

Apr 29, 2016

Abbott Labs sees $25B St Jude purchase improving its negotiating clout vs hospital customers: on.wsj.com/1SMlPOJ via @WSJ @joewalkerWSJ

Apr 28, 2016

AbbVie Agrees to Buy Cancer-Drug Developer Stemcentrx for $5.8 billion, Reports Jump in Earnings on.wsj.com/1SMyH7f via @WSJ $ABBV

Apr 27, 2016

RT @JeanneWhalen: We're streaming the Senate hearing on Valeant & drug pricing. Outgoing CEO Mike Pearson to testify in a bit: https://t.co…<a title="http://online.wsj.com/public/resources/documents/live-video-event.html?mod=e2tw" href="https://t.co/8v5hnYC9yZ" rel="nofollow" target="_blank">online.wsj.com/public/resourc…

Apr 27, 2016

The 2 whistleblowers in this case - including repeat plaintiff William LaCorte -- are sharing a $98 million cut.. twitter.com/TheJusticeDept…

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.